Netherlands
NL
Dutch Pharmacists Association (KNMP) Launches Public Campaign on Medication Safety
The Royal Dutch Pharmacists Association continues its "Samen met je apotheker" (Together with your pharmacist) public awareness initiative, positioning pharmacists as medication specialists in healthcare. The campaign aims to strengthen public trust in pharmaceutical counseling and medication management across the Netherlands.
Source: KNMP News
NL
CBG-MEB Continues Regulatory Framework Updates for Medicines
The Dutch Medicines Evaluation Board (CBG-MEB) has reinforced marketing authorization requirements, including mandatory registration in the EMA's Organization Management Service (OMS) database for all marketing authorization holders, manufacturers, and distributors as of January 2022.
Source: CBG-MEB
Europe
EU
EMA Marks Strong 2025 with 104 Medicine Recommendations for Marketing Authorization
The European Medicines Agency recommended 104 medicines for marketing authorization in 2025, with 38 representing new active substances never before authorized in the European Union. The recommendations reflect robust pharmaceutical innovation and regulatory efficiency across Europe.
Source: EMA News
EU
EFPIA Emphasizes Accurate, Balanced Pharmaceutical Promotion Standards
The European Federation of Pharmaceutical Industries and Associations (EFPIA) reaffirms that pharmaceutical promotion must be accurate, balanced, honest, and objective. The guidance ensures healthcare professionals can independently judge therapeutic value and reflects the unique nature of medicinal product communication.
Source: EFPIA
EU
Digital Marketing Strategies Challenge European Pharma Companies
European Pharmaceutical Review reports that pharma companies are struggling to tailor digital marketing messages to individual healthcare providers, missing critical personalization opportunities in the evolving digital landscape. Solutions focusing on provider-specific engagement are emerging as key differentiators.
Source: European Pharmaceutical Review
Global
Global
FDA Launches Unprecedented Crackdown on Deceptive Drug Advertising
The FDA has intensified enforcement against misleading direct-to-consumer pharmaceutical advertisements, dispatching thousands of warning letters over six months—more than the entire preceding decade. The agency reports that 88% of advertisements for top-selling drugs violate FDA fair-balance guidelines.
Source: FDA News
Global
FDA Warns 30 Telehealth Companies Against Illegal GLP-1 Marketing
The FDA issued warning letters to 30 telehealth companies marketing compounded GLP-1 drugs illegally. This marks the second enforcement wave targeting misleading direct-to-consumer pharmaceutical advertising, signaling the agency's commitment to protecting consumers from false claims in digital channels.
Source: FDA News
Global
Pharma TV Ad Spending Drops in May as Migration from Linear TV Accelerates
May 2026 saw the top 10 pharma brands spend $221.1 million on TV drug advertising, continuing a downward trend as companies shift investment away from traditional television. AbbVie's Skyrizi led spending, followed by Dupixent and Tremfya, reflecting a strategic pivot toward digital channels.
Source: FiercePharma
Global
2026 Forecast: Pharma Advertising Dollars Continue Shifting from Traditional TV
Industry analysis shows pharma companies are reallocating advertising budgets away from traditional television toward digital and emerging channels. The trend reflects changing consumer media consumption patterns and the need for more targeted, personalized pharmaceutical marketing approaches.
Source: FiercePharma
Global
AI Shifts from Analysis to Action in Pharmaceutical Marketing
Pharmaceutical companies are moving beyond analytical AI applications toward actionable AI-driven marketing strategies. Machine learning is enabling teams to understand why certain messages underperform and adjust campaigns in real-time, transforming the omnichannel marketing ecosystem in 2026.
Source: PharmaVoice
Global
Novo Nordisk's Wegovy Reduces TV Ad Spend Amid Evolving Marketing Strategy
Novo Nordisk cut Wegovy TV advertising spend by 24% between April and May 2026, from $31.6 million to $24.1 million. The reduction underscores the industry's broader shift toward digital and omnichannel strategies over traditional broadcast media investment.
Source: FiercePharma
Global
PharmaMarketing Summit 2026 Convenes May 14-15 in San Diego
Marcus Evans is hosting an exclusive PharmaMarketing Summit bringing together leading pharmaceutical marketing executives with innovative suppliers. The May 14-15 event in San Diego focuses on industry trends, simplification strategies, and meaningful healthcare provider engagement in an increasingly digital landscape.
Source: PM360
Global
FDA Hosts REdI Conference on Innovative Regulatory Strategies May 19-20
The FDA's Regulatory Education for Industry (REdI) Annual Conference 2026 convenes May 19-20, featuring discussions on innovative regulatory strategies to advance medical products. The conference brings industry stakeholders together to address emerging challenges in drug advertising and regulatory compliance.
Source: FDA News
📈 Trends to Watch
Digital-First Marketing: The pharmaceutical industry's migration away from traditional TV accelerates as companies invest heavily in targeted digital strategies and omnichannel engagement. AI-powered personalization is becoming essential for reaching healthcare professionals and patients effectively.
Regulatory Enforcement Intensity: FDA enforcement actions on misleading drug advertising have reached unprecedented levels. Pharma companies must prioritize compliance across all channels, especially digital and social media, where fair-balance requirements are frequently violated.
Simplified Engagement Strategies: Industry leaders are adopting "less is more" marketing philosophies in 2026, removing unnecessary digital layers and focusing on meaningful, simplified engagement that delivers ROI rather than marketing complexity.